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Abstract
Background: For patients with axillary lymph node metastases from breast cancer, performance of a complete
axillary lymph node dissection (ALND) is the standard approach. Due to the rich lymphatic network in the axilla, it
is necessary to carefully dissect and identify all lymphatic channels. Traditionally, these lymphatics are sealed with
titanium clips or individually sutured. Recently, the Harmonic Focus®, a hand-held ultrasonic dissector, allows
lymphatics to be sealed without the utilization of clips or ties. We hypothesize that ALND performed with the
Harmonic Focus® will decrease operative time and reduce post-operative complications.
Methods: Retrospective review identified all patients who underwent ALND at a teaching hospital between
January of 2005 and December of 2009. Patient demographics, presenting pathology, treatment course, operative
time, days to drain removal, and surgical complications were recorded. Comparisons were made to a selected
control group of patients who underwent similar surgical procedures along with an ALND performed utilizing
hemostatic clips and electrocautery. A total of 41 patients were included in this study.
Results: Operative time was not improved with the use of ultrasonic dissection, however, there was a decrease in
the total number of days that closed suction drainage was required, although this was not statistically significant.
Complication rates were similar between the two groups.
Conclusion: In this case-matched retrospective review, there were fewer required days of closed suction drainage
when ALND was performed with ultrasonic dissection versus clips and electrocautery.
Background
Complete axillary staging is a critical component of the
management of advanced breast cancer. Currently, for
patients with no clinical evidence of axillary metastases,
this information is obtained via sentinel node biopsy[1].
However, for patients with pathologically confirmed
axillary metastases via positive sentinel node biopsy or
percutaneous axillary biopsy complete axillary lymph
node dissection (ALND) should be considered [2,3].
Although the recent results of ACOSOG Z0011 trial
suggest that patients with T1/T2 tumors undergoing
breast conserving therapy do not require completion
axillary dissection, patients with more advanced lesions,
patients undergoing total mastectomy and patients with
palpable nodes continue to require ALND for staging
and to reduce the risk of axillary recurrence [4]. Com-
plete axillary node dissection, although necessary, con-
tinues to carry the risks of complications such as
seroma, chronic lymphatic leaks and lymphedema.
The axilla is filled with a rich lymphatic network that
requires careful dissection to identify all channels. Tra-
ditionally, ALND has been performed using titanium
clips and suture ligation along with bovie electrocautery
[5]. Inadequate sealing of lymphatics can result in lym-
phatic leaks, infection, lymphedema and seromas[6].
The frequency of these complications can vary from 3-
85% for seroma formation and 5-49% for lymphedema
[6-12].
Recently, ultrasonic devices have been developed
which allow for precise simultaneous cutting and
hemostasis with minimal damage to surrounding tissues.
It functions by denaturing collagen and elastin in tissue
bundles, vessel walls, and lymphatics to form a coagu-
lum[5]. Ultrasonic dissection provides the ability to seal
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vascular and lymphatic conduits with limited collateral
damage.
The Harmonic Focus® is a handheld ultrasonic dissec-
tion device which allows lymphatics to be sealed without
utilization of clips or ties. It has been available since
October 2007 and is designed for open procedures. It
has been used for dissection in surgery of the liver, gall-
bladder, thyroid and breast [13-18]. It has been used in
other lymphatic dissections in an attempt to reduce
lymphatically related complications and has been shown
to reduce operative times and reduce lymphatic spillage
with similar rates of lymph node harvest for both modi-
fied lateral neck dissections and central neck dissections
in thyroid cancer[16,17]. The ultrasonic dissector has
also been shown to reduce blood loss[12].
We hypothesize that ALND performed with Harmonic
Focus® will decrease operative time and post-operative
complications. Here we present our pilot study investi-
gating the role of Harmonic Focus® as method to
reduce axillary complications.
Methods
All women at the University of Texas Southwestern
Medical Center undergoing ALND for confirmed breast
cancer metastasis from January 1, 2005 to December 1,
2009 were eligible. Nearly 250 ALND’s were performed
during this time period. In 2007, ultrasonic dissection
became the standard technique for ALND for 3 fellow-
ship trained breast surgeons (RR, AM, DE) at this large,
high volume, academic medical center. Twenty eight
patients underwent ALND with the Harmonic® scalpel.
Patient records were reviewed after IRB approval. These
patients were then matched for number and type of pro-
cedures performed at the time of ALND with thirteen
historical case controls by procedure performed by the
same surgeons. All patients had pathologically con-
firmed axillary metastasis prior to ALND by either senti-
nel node biopsy or percutaneous axillary biopsy.
Additionally, none of the patients in either group had
breast reconstruction at the time of axillary dissection.
Due to the surgeon preference for utilizing ultrasonic
dissection once it became available, one to one matched
pair analysis was not possible, however, the thirteen
controls reviewed were performed by the same surgeons
that performed the ultrasonic dissections to minimize
surgeon specific variables.
Surgery
Skin incisions were made with a scalpel. If concurrent
breast surgery occurred at the time of ALND, mastect-
omy was performed using either tumescent technique or
bovie electrocautery. For axillary lymphadenectomy, all
tissue inferior to the axillary vein, between the anterior
border of the latissimus dorsi and medial to the border
of the pectoralis minor was removed, thus including all
level 1 and 2 nodes. The axilla was closed with 3.0
Vicryl interrupted suture and the skin was re-approxi-
mated with 4.0 Monocryl. At the time of surgery, 1
closed suction 19 french Jackson-Pratt drain was placed
for patients with partial mastectomy and axillary dissec-
tion and 2 closed suction drains were placed for modi-
fied radical mastectomy patients. Drains were then
removed on an outpatient basis when output was less
than 30 cc/day for 2 consecutive days. Operative time
was obtained by review of the anesthesia record and
operating room nurse record. Patients were discharged
routinely on postoperative day one with drains in place
and self recorded the output after teaching.
Incidence of ipsilateral lymphedema, seroma and
wound complications was noted upon review of follow-
up appointments in any department (Surgery/Radiation
Oncology, Medical Oncology or Emergency depart-
ment). Categorical variables were analyzed using c2 test,
continuous variables were analyzed using ANOVA test-
ing using SPSS 12.0. All endpoint analyses were ana-
lyzed using paired t-test. Multiple comparisons were not
adjusted for.
Results
Over the 2 year period, 28 patients underwent axillary
dissection using Harmonic scalpel®. Median follow-up
time for both groups was 2.0 years. Patients in both
groups had similar demographics as well as pathology
and exposure to chemotherapy (Table 1). Additionally,
there was no statistically significant difference in T stage
between the control and ultrasonic dissection group (p
= 0.222). Patients were matched to controls undergoing
similar procedures by the same surgeons (Table 2).
There were no differences in operative time, post-
operative day 1 output or overall complications between
the groups. There was a difference in days to drain
removal (15.9 vs 12.4 days p = 0.07), however, this was
not statistically significant. There was no difference in
rates of seromas, wound complications or lymphedema
between the two groups (Table 3).
Discussion
Given the significant morbidity of ALND and the costs
associated with their management, multiple studies have
tried to identify risks factors as well as methods to
reduce complications. Risk factors for seroma formation
include MRM rather than PM[9], use of electrocautery
for ALND[19], older age, patient weight, BMI[20] and
drainage output at 48 hours (>50 cc/day)[21]. The role
of axillary drainage has been a particular area of focus.
Drains have been shown to reduce seroma rates com-
pared to no drainage at all[21-23]. Lower overall drain
volume[24], days to drain removal[25,26] and drainage
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less than 30-50 cc/day[27] prior to removal have all
been shown to reduce seroma formation.
Given the observed residual dead space after ALND,
attempts have been made to use hemostatic agents to
reduce seroma formation. Use of thrombin spray failed
to show any significant reduction in seroma formation
or days required for closed suction drainage[22]. In a
prospective randomized trial, the use of fibrin glue did
not prevent or reduce seroma formation, aspiration
volume, or complications[28]. Similarly, Berger found no
difference in axillary drainage time, seroma formation,
drain volume or local inflammation following use of a
fibrin glue coated collagen patch[29]. Use of argon beam
decreased operative blood loss, but not seroma forma-
tion[30].
Variances in surgical technique have also been
explored. Classe JM et al attempted to reduce hospital
stays by using axillary padding and 3 layered closure of
the axilla rather than closed suction drainage, there
were no differences in post-operative seroma rates (p =
0.9) or needle aspiration (p = 0.94)[31]. Wound closure
by suturing skin flaps to the axillary space resulted in
longer operative times, but did decrease the number of
days until drain removal, as well as overall drain volume
thereby resulted in reduced rates of seroma formation
[32]. Additionally, several studies have evaluated the fea-
sibility of axillary reverse mapping (ARM) a technique
in which one can intraoperatively map the axilla [33,34]
In a small pilot study this was shown to prevent lym-
phedema[35]. Another newer technique is LYMPHA,
which entails a lymphatic to venous anastomosis at the
time of axillary dissection [36]. Lymphedema (as defined
as increase in arm volume at serial follow-up measure-
ments) in this study, at 18 month follow-up, was defined
by a reduction in arm circumference. After ALND with
LYMPHA, only 4.4% of patients developed lymphedema,
versus 30% in patients who underwent ALND alone
[36].
Investigators have also attempted to use ultrasonic
dissectors (Ligasure® device) in a similar fashion to that
presented here. Galatius et al found no differences in
seroma incidence using the ultrasonic dissector, how-
ever, overall seroma rate was 66% and all drains were
removed on post operative day 5 regardless of output
[37]. Lumachi et al found there was no reduction in ser-
oma rate using this method but did find on univariate






Age at Diagnosis 49.4 52 P = 0.415
BMI 25 31.1 P = 0.090
Ethnicity P = 0.234
White 43% (n = 5) 21% (n = 6)
Black 21% (n = 3) 42% (n = 12)
Hispanic 29% (n = 4) 25% (n = 7)
Asian 0 11% (n = 3)
Other 7% (n = 1) 0
Tumor Size 3.4 3.91 P = 0.545
Clinical T Stage P = 0.222
T1 N = 6 N = 6
T2 N = 2 N = 11
T3 N = 4 N = 6
T4 N = 1 N = 5
Histology P = 0.378
Invasive ductal 11 (79%) 24 (86%)
Invasive lobular 1 (14%) 2 (7%)
Other 1 (7%) 0
Combination 0 2 (7%)
Type of Surgery P = 0.566
PM 5 10
TM 8 18
Neoadjuvant chemotherapy 43% (n = 6) 32% (n = 9) P = 0.614
Adjuvant chemotherapy 78% (n = 11) 79% (n = 22) P = 0.601
BMI = body mass index PM = partial mastectomy, TM = total mastectomy





ALND alone 3 3




MRM+ mediport 1 1
TM+SLNB+ALND 1 2
ALND+TM+ mediport+ contralateral SLNB
+contralateral TM
2 5
*minor procedure included sentinel node biopsy, partial mastectomy, or
mediport placement
ALND = axillary lymph node dissection, PM = partial mastectomy, SLNB =
sentinel node biopsy, MRM = modified radical mastectomy, TM = total
mastectomy
Table 3 Endpoint Analysis
Control n = 13 Harmonic n = 28 P value
Operative Time * 208.5 min 209 min P = 0.965
Output POD#1 * 134 cc 134.4 cc P = 0.982
Days JP remained* 15. 9 days 12. 4 days P = 0.07
Complications 4 (31%) 10 (36%) P = 0.788
Seroma 2 (15.4%) 2 (7%) P = 0.377
Wound infection 1 (8%) 4 (13%) P = 0.486
Lymphedema 0 (0%) 4 (13%) P = 0.170
* = paired t test
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analysis that risk factors for seroma formation included
BMI, tumor size, number of involved nodes, total drai-
nage before drain removal and time to drain removal
[38].
This is the first investigation in an American institu-
tion, evaluating the use of the Harmonic Focus® to
reduce complications for ALND. Adwani et al found
decreased blood loss but no difference in days until
drain removal, seroma formation or number of treat-
ments for seromas, and were thus unable to show
improved outcomes in England[18]. An Indian study
similarly found reduced blood loss but also found
reduced drainage volume and drainage days but found
no difference in seroma formation or operative time
(seroma rate 16% vs 22%)[39]. Manouras et al in Greece
found no complications with the use of the Harmonic®
scalpel for ALND in 60 patients at 3 years of follow-up
[40]. Although impressive, only 22% of these patients
had positive nodes, a factor which has been shown to
increase the risk for axillary complications. Additionally,
comparisons may be difficult as the majority of these
patients had lower stage tumors (5% T3) than the pre-
sent study[41].
We found fewer days to drain removal with the use of
ultrasonic dissection. Although there was no difference
in operative time, seroma formation, wound complica-
tions or lymphedema, reduced drainage time has been
shown to reduce complication rates[20]. Larger studies
with increased statistical power may be able to detect
other differences. Many of our patients had bilateral
procedures done at the time of ALND with and without
immediate reconstruction, which increases expected
operative times and increases the risk of complications.
The Harmonic® scalpel, in addition to reducing the
days of drain placement, can also potentially reduce
healthcare costs. Fewer days of drainage can reduce the
number of clinic visits and potentially the need for addi-
tional studies. Also, there is a potential for reduced
costs of equipment given that the current institutional
cost of an automatic clip applier is $185, with the use of
2-3 per case and the Harmonic Focus® is approximately
$400.
By allowing faster removal of closed suction drainage
after ALND, Harmonic focus® may allow a more rapid
transition to the initiation of systemic therapy as sug-
gested by our pilot study.
Conclusions
In this retrospective, pilot study, the use of ultrasonic
dissection resulted in trends suggesting decreased days
of closed suction drainage when compared to traditional
techniques utilizing clips and electrocautery. Ultrasonic
dissection was not associated with decreased operative
time or lower rates of post-operative complications.
Further studies with larger sample sizes are required to
confirm these results.
Abbreviations
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